Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 7,839 | 7,912 | 10,594 | 8,896 | 5,848 |
Cost of Goods | 4,342 | 4,116 | 5,368 | 4,590 | 2,888 |
Gross Profit | 3,497 | 3,796 | 5,226 | 4,306 | 2,960 |
Operating Expenses | 8,910 | 9,379 | 9,460 | 9,516 | 12,547 |
Operating Income | -5,071 | -5,467 | -3,866 | -4,620 | -8,699 |
Interest Expense | 596 | 1,407 | 212 | 142 | 79 |
Other Income | 5,430 | -3,562 | 7,598 | -1,579 | -1,045 |
Pre-tax Income | -237 | -10,436 | 3,520 | -6,341 | -9,823 |
Income Tax | 20 | 1 | -6 | 1 | 14 |
Net Income Continuous | -257 | -10,437 | 3,526 | -6,342 | -9,837 |
Net Income | $-257 | $-10,437 | $3,526 | $-6,342 | $-9,837 |
EPS Basic Total Ops | -0.05 | -2.88 | 4.45 | -4.64 | -7.23 |
EPS Basic Continuous Ops | -0.05 | -2.88 | 4.45 | -4.64 | -7.23 |
EPS Diluted Total Ops | -0.05 | -2.88 | 4.45 | -4.64 | -7.23 |
EPS Diluted Continuous Ops | -0.05 | -2.88 | 4.45 | -4.64 | -7.23 |
EPS Diluted Before Non-Recurring Items | -1.12 | -1.85 | -2.33 | -4.64 | -6.14 |
EBITDA(a) | $-4,762 | $-5,160 | $-3,571 | $-4,369 | $-8,447 |